Mayne Pharma Group Limited (ASX:MYX – Get Free Report) insider Kathryn MacFarlane bought 18,000 shares of the business’s stock in a transaction on Wednesday, October 25th. The shares were acquired at an average price of A$3.84 ($2.45) per share, for a total transaction of A$69,120.00 ($44,025.48). Mayne Pharma Group Stock Performance The company has a […]
Mayne Pharma Group Limited (ASX:MYX – Get Free Report) insider Kathryn MacFarlane purchased 18,000 shares of the stock in a transaction dated Wednesday, October 25th. The shares were bought at an average price of A$3.84 ($2.43) per share, with a total value of A$69,120.00 ($43,746.84). Mayne Pharma Group Stock Performance The company has a debt-to-equity […]
Mayne Pharma Group Limited (ASX:MYX – Get Free Report) insider Ann Custin purchased 6,250 shares of the company’s stock in a transaction that occurred on Friday, October 20th. The shares were acquired at an average price of A$3.35 ($2.12) per share, for a total transaction of A$20,918.75 ($13,239.72). Ann Custin also recently made the following […]
Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Patrick Blake bought 3,097 shares of the business’s stock in a transaction on Thursday, April 13th. The stock was purchased at an average cost of A$4.07 ($2.73) per share, with a total value of A$12,592.40 ($8,451.28). Mayne Pharma Group Stock Performance The company has a debt-to-equity […]
Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Ann Custin bought 9,075 shares of the stock in a transaction dated Monday, April 17th. The shares were bought at an average cost of A$4.06 ($2.72) per share, with a total value of A$36,844.50 ($24,727.85). Mayne Pharma Group Price Performance The company has a quick ratio […]